ACRO BIOMEDICAL CO., LTD. (ACBM) › Operating IncomeACRO BIOMEDICAL CO., LTD. (ACBM) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2016: $43.4K2017: -$2.2K2018: $515.5K2019: -$422.8K2020: -$130.5K2021: -$7.69M2022: -$15.87M2023: -$8.80M2024: -$38.0K2025: -$154.0K-$154.0K2016Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$154.0K-305.8%2024-$38.0K+99.6%2023-$8.80M+44.5%2022-$15.87M-106.3%2021-$7.69M-5797.1%2020-$130.5K+69.1%2019-$422.8K-182.0%2018$515.5K+23033.7%2017-$2.2K-105.2%2016$43.4K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share